PortfoliosLab logo

Acerus Pharmaceuticals Corporation (ASP.TO)

Equity · Currency in CAD · Last updated Jun 25, 2022

Company Info

ISINCA00444G4051
CUSIP00444G405
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

ASP.TOShare Price Chart


Chart placeholderClick Calculate to get results

ASP.TOPerformance

The chart shows the growth of CA$10,000 invested in Acerus Pharmaceuticals Corporation on Aug 24, 2011 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$90 for a total return of roughly -99.10%. All prices are adjusted for splits and dividends.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

ASP.TOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-43.04%-0.75%
YTD-62.50%-19.93%
6M-62.50%-20.27%
1Y-71.88%-10.86%
5Y-38.82%6.71%
10Y-41.13%9.59%

ASP.TOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ASP.TOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acerus Pharmaceuticals Corporation Sharpe ratio is -0.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

ASP.TODividend History


Acerus Pharmaceuticals Corporation doesn't pay dividends

ASP.TODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

ASP.TOWorst Drawdowns

The table below shows the maximum drawdowns of the Acerus Pharmaceuticals Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acerus Pharmaceuticals Corporation is 99.75%, recorded on Jun 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.75%Apr 16, 20122559Jun 24, 2022
-20%Oct 3, 20113Oct 5, 20113Oct 11, 20116
-18.82%Dec 2, 201113Dec 20, 201131Feb 6, 201244
-15.67%Feb 17, 20127Feb 28, 201230Apr 11, 201237
-15.2%Aug 25, 201113Sep 13, 20116Sep 21, 201119
-9.43%Nov 22, 20112Nov 23, 20112Nov 25, 20114
-8.7%Feb 10, 20121Feb 10, 20121Feb 13, 20122
-6.15%Sep 23, 20114Sep 28, 20112Sep 30, 20116
-5.84%Oct 13, 20118Oct 24, 20111Oct 25, 20119
-5.06%Nov 2, 20111Nov 2, 20113Nov 7, 20114

ASP.TOVolatility Chart

Current Acerus Pharmaceuticals Corporation volatility is 154.44%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

Portfolios with Acerus Pharmaceuticals Corporation


Loading data...